PMID: 8976118Dec 1, 1996Paper

Hyperuricemia in hematological disorders

Nihon rinsho. Japanese journal of clinical medicine
J Iwata

Abstract

Hyperuricemia is a common manifestation in various hematological disorders such as hemolytic anemias, megaloblastic anemia malignant lymphomas and leukemias. Tumor lysis syndrome (TLS) is a serious complication consists of hyperuricemia, hyperkalemia, hyperphosphatemia and hypocalcemia due to massive cell lysis, which occurs shortly after the onset of chemotherapy or radiotherapy for acute leukemias and malignant lymphomas. Acute renal failure may develop due to uric acid nephropathy. The risk factors of TLS are heavy tumor cell burden, rapid cell turn over rate and renal involvement of neoplastic cells. To prevent and control TLS, adequate intravenous hydration to keep patient's urine volume, alkalization of urine by sodium bicarbonate and inhibition of uric acid production by high dose allopurinol is recommended.

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Nature Clinical Practice. Oncology
Elvira RampelloMariano Malaguarnera
Expert Review of Hematology
Giulia MalaguarneraMariano Malaguarnera
Gan to kagaku ryoho. Cancer & chemotherapy
Takeshi Hagino
© 2022 Meta ULC. All rights reserved